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GABAA receptor binding is transiently increased in rat whisker barrels during the 
second postnatal week, at a time when neurons in the developing rat cortex are vulnerable 
to excitotoxic effects.  To test whether these GABAA receptors might serve to protect 
neurons from excessive excitatory input, polymer implants containing the GABAA 
receptor antagonist bicuculline were placed over barrel cortex for a 4-day period in young 
(postnatal days 8 – 12) and adult rats.  In the cortex of young, but not adult rats, the 
chronic blockade of GABAA receptors resulted in substantial tissue loss and neuron loss.  
The greater loss of neurons in young rats supports the hypothesis that a high density of 
GABAA receptors protects neurons from excessive excitatory input during a sensitive 
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CHAPTER I  
INTRODUCTION 
 
GABA is the major inhibitory neurotransmitter in the cortex.  During the second 
postnatal week, there is a transient peak in GABAA receptor binding in rat whisker 
barrels.  To investigate the role of transient increase in GABAA receptor binding, the 
barrel cortex of both developing and adult rats was exposed to polymer implants that 
release bicuculline, a specific GABAA receptor antagonist.  Effects of bicuculline versus 
control implants were analyzed in Nissl-stained sections.  In young but not adult rats, 
bicuculline administration was associated with significant tissue and neuron loss.  In this 
first investigation of a chronic in vivo blockade of GABAA receptors in rat cortex, the 
results suggest a neuroprotective role of GABAA receptors in the developing rat cortex.  
 
Development of Barrel Cortex  
The posteromedial barrel field of rat somatosensory cortex, because of its 
transient increase in GABAA receptor binding, serves as a good model for studying 
developmental roles of cortical GABAA receptors.  In the well defined whisker-to-barrel 
pathway, facial vibrissae correspond somatotopically to a specific clustering of cells 
called barrelettes in the brain stem, barrelloids in the thalamus, and barrels in cortex 
(Woolsey, 1967; Woolsey et al., 1975; Welker, 1976).  At approximately postnatal day 3 
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(P3), cells in cortical layer IV begin to aggregate in barrel-like patterns imposed by the 
spatial pattern of the thalamocortical axons.  During second postnatal week in the 
development of the somatosensory cortex, there is dramatic branching of dendrites and 
synaptogenesis within layer IV (Rice, 1985; Rice et al., 1985; Micheva and Beaulieu, 
1996).  Around P8-P12, GABAA receptor binding is transiently increased in cortical 
whisker barrels to almost two times that of the newborn or adult (Fuchs, 1995).  
 
GABA and GABAA Receptor Development in the Cortex 
γ-Aminobutyric acid (GABA) is the predominant inhibitory neurotransmitter in 
the cortex.  From embryonic day 18 until the first part of the second postnatal week, 
GABAergic synapses in the rat cortex can generate membrane depolarization (Cherubini 
et al., 1990; Luhmann and Prince, 1991).  GABA-induced depolarization may be due to 
the depolarized Cl- equilibrium potential found in young neurons (Cherubini et al., 1990), 
but it may also be due to an under-developed Cl- "transport system" (Plotkin et al., 1997) 
which allows an influx, rather than efflux, of chloride ions into the cell.  Maturity of the 
inhibitory system associated with the GABAergic transition from depolarizing to 
hyperpolarizing activity may also depend on the establishment of complex cortico-
cortical synapses (Lund and Harper 1991), or on the developmental changes in receptor 
subunits (Cherubini et al., 1998; Soldo et al., 1998).  By the end of the first postnatal 
week, GABAergic responses are inhibitory (Plotkin et al., 1997; Luhmann and Prince, 
1991). 
In autoradiographic studies of the adult rat parietal cortex, approximately 70% of 
[3H]GABA binding is to the GABAA site (Bowery et al., 1987; Chu et al., 1990).  In the 
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whisker barrel of the somatosensory cortex of rats, [3H]muscimol binding to GABAA 
receptors is relatively low from P0-P4.  Around P8-P12, GABA receptor binding is 
transiently increased in cortical whisker barrels to almost two times that of the newborn 
or adult (Fuchs, 1995). 
In postnatal cortical development, spatiotemporal patterns of neurotransmitter 
receptor binding generally change (Murrin et al., 1985; Dam et al., 1988; Palacios et al., 
1988; Fuchs, 1995).  In several cases, neurotransmitter receptor binding increases 
transiently during brain development (see Table 1).  As with muscimol binding, the 
transience typically occurs in areas that receive direct thalamic input, such as in layer IV 
of the primary somatosensory or visual cortex (Insel et al., 1990; Fuchs, 1995).  While 
the purpose of transient increases in receptors is not known, perhaps the developmental 
changes in receptors assist in cortical organization, maturation, or even neuronal survival 
(review: Zilles et al., 1991; Fuchs, 1995). 
 
Development of Glutamate Receptors and Excitotoxicity 
Glutaminergic (Kaneko and Mizuno, 1988; Kharazia and Weinberg, 1994) 
thalamic afferents terminate in layer IV in the barrel cortex (Chmielowska et al., 1989).  
These receptors, functional from birth (Kim et al., 1995), play an important role in 
synaptic maturation (reviews: McDonald and Johnston, 1990; Kaczmarek et al., 1997; 
Anwyl, 1999). Glutamate receptors in barrels also demonstrate transience during 
development (Insel et al., 1990; Kossut et al., 1993; Monyer et al., 1994; Blue and 
Johnston, 1995; Glazewski et al., 1995; Blue et al., 1997).  For example, in the rat barrel 
field cortex, [3H]glutamate binding to NMDA receptors increases to a peak at P21 (Blue 
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and Johnston, 1995), while [3H]glutamate binding to quisqualate receptors peaks in the 
barrel centers at approximately P10 and then decline to adult levels by P21 (Blue and 
Johnston, 1995). 
Excitotoxicity, which can result from an over-activation of excitatory amino acid 
receptors (Choi, 1992; Olney, 1994), may initiate a cascade of cellular events that 
produce neuronal injury and death in the developing rat brain (McDonald et al., 1988).  
Perhaps due to the slower maturation of the inhibitory system (Burgard and Hablitz, 
1993), there is a transient vulnerability of cortical neurons to seizure activity (Kaminogo, 
1983; Luhmann and Prince, 1991; Agmon and O'Dowd, 1992). In the second postnatal 
week, there is also a transient sensitivity to excitotoxic injury and cell death by AMPA 
(McDonald et al., 1992) and NMDA (McDonald et al., 1988; McDonald and Johnston, 
1990; Carmignoto and Vicini, 1992; Deisz and Luhmann, 1995; Johnston, 1994, 1995).  
Given the coincident timing of increased glutamate sensitivity and the high levels of 
GABAA receptors during the second postnatal week, it is conceivable that the temporary 
increases in GABAA receptors serve to protect cortical neurons from glutamate receptor 
mediated excitotoxicity. 
GABAA Receptor Blockade 
Small changes in the balance between cortical excitation and inhibition during 
development can lead to changes in cortical structure and function (Charpier and Deniau, 
1997; Wallace and Fox, 1999).  GABA, through its hyperpolarizing effects on neurons, 
serves to balance excitatory neurotransmission, and contributes to the overall level of 
cortical activity (Tasker and Dudek, 1991; Bernardo and Wong, 1995; Burgard and 
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Hablitz, 1993; Douglas et al., 1995).  Both development and maintenance of inhibitory 
circuits contribute to neuronal survival (Mattson and Kater, 1989; Ikeda et al., 1997).  
Bicuculline can block the inhibitory effects of GABAA receptor mediated activity 
(Curtis et al., 1971).  Blockade of cortical GABAA receptors can lead to increased activity 
and epileptiform activity, both in vivo (Pernberg et al., 1998) and in vitro (Chagnac-
Amitai and Connors, 1989; Burgard and Hablitz, 1993).  Blockade of GABAA receptors 
can also influence NMDA receptor activity (Luhmann and Prince, 1990; McCormick et 
al., 1993).  Beginning at approximately P6-P8, bicuculline can increase excitatory 
postsynaptic potentials by electrical stimulation (Burgard and Hablitz, 1993) and lead to 
epileptiform bursting by P9 (Burgard and Hablitz, 1993). 
In vivo, ionophoretic application of bicuculline increases the electrophysiological 
activity of cortical neurons (Hicks and Dykes, 1983; Kyriazi et al., 1998).  Locally 
applied bicuculline has also been used to induce focal seizures (Soukupova et al., 1993; 
Stein et al., 2000).  Cell injury following bicuculline-induced seizures has been 
demonstrated in rats (Soderfeldt et al., 1981, 1983; Turski et al., 1985; Sasahira et al., 
1995).  To block GABAA receptors, intraperitoneal (i.p.) bicuculline injections have often 
been employed. Developing rats show epileptiform seizures including shaking, rearing, 
and alternating muscle contraction and relaxation, known as clonus following i.p.  
injections of bicuculline (Turski et al., 1985; Zouhar, 1989; Baram and Snead, 1990).  
However, bicuculline injections are also accompanied by pulmonary edema and 
decreased cerebral oxygenation (Kiessling et al., 1981; Soderfeldt et al., 1983; Kreisman 
et al., 1987).  By applying the GABAA receptor antagonist, bicuculline methiodide (BMI) 
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The implant material used was an ethylene vinyl acetate copolymer (Evatane, Elf 
Atochem North America, Philadelphia, PA) similar to Elvax 40P (Dupont).  These 
polymers have been used to deliver drugs locally, bypassing systemic interaction and 
degradation.  They also have an advantage over osmotic pumps and iontophoresis that are 
not designed for chronic applications in small mammals like the developing rat.  In vivo, 
Elvax and similar polymer implants have been successfully used to deliver insulin, 
growth factors, immunoglobulins, neurotransmitters, or their antagonists (Table 2).  
Release of drugs within hours of implantation has been demonstrated in vivo (TTX: 
Chiaia et al., 1992; [3H]APV: Fox et al., 1996) for a period of one week (Schlagger et al., 
1993) and longer (Schnupp et al., 1995; Smith et al., 1995; Mooney et al., 1998; Prusky 







Examples of Receptors Displaying Transience During Rat Cortical Development 
 
Receptor Type Method Reference 
GABAA A 
Schliebs and Roth, 1988; Kumar 
and Schliebs, 1993; Fuchs, 1995 
GABAB A Turgeon and Albin, 1994 
Benzodiazepine A Schliebs et al., 1986 
A 
Insel et al., 1990; Blue and 
Johnston, 1995 NMDA 
A, I Brennan et al., 1997 
A Insel et al., 1990; Miller et al., 1990 
Kainate / Quisqualate 
A, I 
Blue and Johnston, 1995; Brennan 
et al., 1997 
Metabotropic glutamate A Blue et al, 1997 
Nicotinic acetylcholine A Fuchs, 1989 
A Kumar and Schliebs, 1992 
Muscarinic acetylcholine 
I Buwalda et al., 1995 
 





Examples of In Vivo Use of Polymer Implants in Rat 
 
Reference Substance Delivered Age  Exposure Periods 




P8 2 - 12 days 
Boison et al., 1999 Adenosine Adult 1 - 14 days 
Brown et al., 1986 [3H]Insulin Adult 100 days 
Chiaia et al., 1992; 1994 TTX P0 6 - 11 days 
Doulazmi et al., 1998 Immunoglobulins P4 – P5 4 - 5 days 
Fox  et al., 1996 APV; [3H]APV P0 3 - 6 weeks 
Graber and Prince, 1999 TTX P28 – P30 10 - 15 days 
Kokaia et al., 1994 GABA; Noradrenaline Adult 2 - 14 days 
Penschuck et al., 1999 
BDNF; MK-801; 
[3H]MK-801 
P0 6 - 14 days 
Persico et al., 1997 
p-Chloroamphetamine 
(PCA) 
P0 6 days 
Rhoades et al., 1996; 1998 TTX P0 6 days 
Rozas et al., 1996 GABA Adult 1 - 14 days 
Schlaggar et al., 1993 APV P0 8 days 








CHAPTER II  
MATERIALS AND METHODS 
 
Polymer Implants 
A 10% solution of ethylene-vinyl acetate copolymer beads (Evatane, Elf Atochem 
North America, Philadelphia, PA, N. 24937-78-8) in methylene chloride was prepared 
using methods previously described (Rhine et al., 1980; Silberstein and Daniel, 1982).  
Evatane (0.049 g) was dissolved in methylene chloride (0.44 ml) and thoroughly mixed 
with 0.01 g BMI, yielding a 40 mM bicuculline methiodide (BMI) solution 
(approximately 200 mg per g polymer).  Implants prepared without a drug were used as 
controls.  The suspension was vortexed for 4-5 min, poured into a pre-cooled glass plate 
or metal mold (6.0 cm X 6.0 cm X 0.3 cm), and kept covered at -80°C for 10 min.  The 
frozen polymer was removed from the metal mold, placed on ParaFilm (American 
National Can, Greenwich, CT), wrapped in foil and sealed in a plastic freezer bag.  The 
polymer remained in the -80°C freezer for 4 days and then was transferred to a -20°C 
freezer for an additional 4 days.  Over the first four days, the polymer block was 
periodically removed from the bag and vented under a fume hood.  The polymer was 
sectioned at 100 µm thickness using a sliding mictrotome (Microm Heidelberg, Zeiss), 
and a stereomicroscope was used to aid in cutting the polymer sheets into 2 mm X 2 mm 
implants.  All implants were wrapped in foil and stored at –20°C.  Prior to use, each 
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implant was presoaked overnight (12-16 hours) in 0.9% saline to avoid a high initial rate 
of release (Reh and Constantine-Paton, 1985).  
 
Subjects 
The subjects were Long-Evans hooded rats (Simonsen, Gilroy, CA).  Rats were 
used at P8, where P0 is the day of birth.  Adult male rats at least 3 months of age, but less 
than 1 year old (268 ± 90 g, mean ± S.D.), were also examined.  Animals were kept on a 
12:12 light-dark cycle, had food and water available ad libitum, and were sacrificed 
between 9:00 and 16:00. 
 
Surgery 
Postnatal day 8 rat pups were anesthetized with inhaled methoxyflurane (Pitman-
Moore, Inc., Mundelein, IL).  A midline incision was made in the scalp, and the fibrous 
sheath of periosteum that covers the bone was removed by gentle scraping.  A circular 2 
mm diameter “window” of skull was removed over the barrel field on each side of the 
midline.  The barrel field in the P8 rat was determined to be located approximately 1.2-
2.1 mm posterior to bregma and 3.0-3.5 mm from midline, (Sherwood and Timiras, 
1970).  The dura mater over SI was removed with a fine-curved microhook, and the 
implant was placed over the exposed cortex.  The BMI implant was placed on either the 
right or the left SI; the control implant was placed on the contralateral side (See Fig. 1).  
All implants were secured by gently tucking the corners of the implant under the skull.  
The incision was held together by alpha-cyanoacrylate and without sutures.  While 
recovering from anesthesia, the animal was warmed in an incubator and returned to its 
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mother within 1 hour.  During recovery and for the four days after implant surgery, there 
were no noticeable seizure-like behaviors (convulsions, whisker twitching).    
  Adult rats were anesthetized with ketamine (100 mg/ml solution, i.p.; 90 mg/kg) 
and xylazine (100 mg/ml solution, i.p.; 10 mg/kg).  Under surgical anesthesia, the head 
was shaved and a midline incision made in the scalp.  Using the same procedure as 
above, the periosteum and the musculature were dissected away from the barrel region.  
In adults, the boundaries of the posteromedial barrel field are located approximately 4.0-
6.0 mm from midline and 0.2 mm anterior to and 2.7 mm posterior from bregma (Paxinos 
and Watson, 1986).  After the implantation, the incision was sutured with 4-0 silk, and 
the animals were returned to their home cages and monitored for recovery.   
 
Tissue Preparation 
 Four days after the implant surgery, animals were deeply anesthetized and perfused 
intracardially with 200 ml room temperature 0.9% saline solution, followed by chilled 
4% paraformaldehyde in 0.1 M phosphate buffer at pH 7.4.  P12 rat pups were 
anesthetized with inhaled Metofane (Pitman-Moore, Inc., Mundelein, IL), and adult rats 
were anesthetized with ketamine (100 mg/ml solution, i.p.; 90 mg/kg) followed by 
xylazine (100 mg/ml solution, i.p.; 10 mg/kg).  Following a 24-48 hour postfixation, 
perfused brains were cryoprotected in 30% sucrose in 0.1 M phosphate buffer for 1 to 2 
days.  Brains were frozen by submersion in –35°C isopentane for 5 minutes, followed by 
-80°C isopentane for 5 minutes, and then were wrapped in foil and stored at –80°C until 
use.  Whole brains were mounted with O.C.T. (TissueTek, Inc. Elkhart, IN), cut at 50 µm 
thickness using a sliding microtome (Microm Heidelberg, Zeiss), and collected in 0.1 M 
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phosphate buffer.  Coronal brain sections were mounted on gelatinized subbed slides and 
stained for Nissl substance with 0.25% thionin.  The stained slides were then dehydrated 
in a series of alcohols, cleared in xylenes, and coverslipped with DPX (BDH Microscopy 
Material Ltd., England). 
 
Data Analysis 
Drawings from each of the Nissl stained sections through the barrel field were made 
using a camera lucida.  Four serial 50-µm coronal sections (a total of 200 µm anterior-
posterior) were chosen to represent the area of maximum damage under the implant.  
Using a camera lucida at a final magnification of 40X, affected areas in each section were 
outlined and measured in mm2 using a digitizing data tablet. 
For each section, effects of bicuculline were calculated as the mean affected area 
on the BMI side minus that on the control side.  Statistical analysis was performed using 
Jandel SigmaStat software.  Effects of age and treatment were assessed with Student’s t-




To assess the effectiveness of bicuculline release from the implant, cortical 
electrophysiological recordings were made under both the control and bicuculline 
implants.  These recordings were performed four days post-implantation (in three P12 
rats), or one day post-implantation (in two P18 rats).  Animals were surgically 
anesthetized with urethane (1.0 g/kg, i.p.; 20% solution) and mounted in a stereotaxic 
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instrument.  After removal of the skin from the surgical area, the implants were removed.  
Within 20 min of implant removal, the first electrical recordings were made by lowering 
a 10 Ω tungsten recording electrode with a 5-µm tip into the center of the implant site.  
Electrical activity was recorded by multiple passes beginning at the surface of the cortex 





Figure 1.  Surgical procedure in a P8 rat.  (A) Anesthetized animal with inhaled 
Metofane.  (B) Window in skull over posteromedial barrel field.  (C) Polymer implants 





CHAPTER III  
RESULTS 
 
Drug Release from Implants 
The coloring of the polymer implant that accompanied the doping of the implant 
indicated that the drug was distributed throughout the polymer.  For example, when the 
polymer was mixed with methylene blue, the implant appeared light to deep blue 
depending on concentration.  The introduction of the 40 mM BMI changed the normally 
clear polymer to a golden yellow.  In vivo and in vitro release of drug from the polymer 
was also assessed by visual inspection.  When implants were retrieved from the cortex 
post-termination, methylene blue implants were lighter in color; BMI implants had 
changed to a pale translucent yellow shade.  These changes in implant color intensity 
were similar to studies in this laboratory, when doped polymer implants were placed in 
saline for four days (unpublished observations).   
Further evidence of drug release in vivo was noted in electrophysiological studies 
following the one or four days of exposure to cortical implants.  Observations of 
multiunit recordings in the P18 animals after the one-day of exposure revealed different 
activity levels under the bicuculline and control implants.  Periodic electrophysiological 
bursting was observed in the cortex under the bicuculline implant, but was not quantified.  
Acute delivery of 40 mM bicuculline methiodide solution to the surface of the cortex in 
one P18 animal resembled the electrophysiological activity after one-day exposure to the 
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bicuculline implant. There was less bursting under the control implant compared to the 
bicuculline implant in these experimental animals. 
In the P12 animals following 4 days of implant exposure, both driven and 
spontaneous electrophysiological activity were increased under the bicuculline implant 
compared to the control implants.  As seen in the example presented in Figure 2, 
spontaneous activity appeared slightly greater under the bicuculline implant than under 
the control implant from the cortical surface to depths of 1200 – 1400 µm.  In the 
developing cortex, these depths correspond approximately to layers I-IV. In a few 
animals, bicuculline-associated increase extended down to layers V and VI.  The increase 
in electrophysiological spontaneous activity under the bicuculline implant compared to 
the control implant suggests GABAA blockade was still effective after four days in vivo.  
Evidence of sustained in vivo drug release is in agreement with results from other studies 




As with other studies using implants (Jablonska et al., 1999; Penschuck et al., 1999) 
brains with hematomas or gross surgical trauma, or whose implants had shifted from the 
barrel region, were not included in the study.  Macroscopically, slight depressions 
remained over the barrel cortex where either implant had been placed.  Microscopic 
examinations of sections under the implants suggested three categories of 
cytoarchitectural effects (see Figs. 3 and 4 and 5).  
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Tissue loss.  Areas with a complete absence of tissue were measured from an 
interpolated cortical surface.  The loss of tissue was generally conical in shape with the 
widest area being directly under the implant, occasionally tapering through all layers of 
cortex. 
Neuron loss.  Nissl-stained sections also contained areas with an apparent loss of 
neurons.  Neurons, which are characteristically large cells with pale cytoplasm, a visible 
nucleus, and darkly staining nucleoli (Vaughan, 1984), were not present in this area, but 
glial cells were seen.  Neuron loss was often seen adjacent to areas of tissue loss. 
Histological disruption.  In addition to tissue and neuron loss under implants, 
some areas contained disrupted lamination or cells with abnormal morphology.  Damaged 
cells appeared similar to those in rat cortex following systemic bicuculline 
administrations, as described by Soderfeldt (1981, 1983).  For example, many neurons 
were shrunken in size and/or had dark staining cytoplasm.  These neurons however, were 
still relatively larger than glia.  There were also degenerating neurons, cells with large 
cytoplasmic vacuoles, and cells containing membrane-bound apoptotic bodies.  Such 
affected cells were not restricted to a specific layer, and were often found adjacent to the 
area of neuronal loss.  Also in this category, there were areas with disturbances in 
numerical cell density and cortical lamination.  Often there was a blurring of the normally 
distinct boundaries of layers IV and V, or general loss in the clarity of the barrel 
cytoarchitecture.  Occasionally, cells and laminae shifted and extended above the 
interpolated normal cortical surface.  This area of  “tissue gain” was subtracted from the 
calculated tissue loss for an area of net tissue loss. 
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Summed Effect.  The total area of cortex affected by the implant was calculated as 
the sum of the areas of tissue loss, neuron loss, and histological disruption. 
 
Data Analysis 
For the pups exposed to implants from P8-P12, effects of implants containing 
bicuculline methiodide were greater than those of the control implant (Table 3).  The area 
of tissue loss was greater by 0.32 mm2 (P < 0.001) and that of neuron loss was greater by 
0.28 mm2 (P < 0.003) (Table 4, Fig. 6).  The area of histological disruption under 
bicuculline implants was not significantly greater than under the control implant (0.90 
mm2, P < 0.07).  The summed effect was significantly greater under the bicuculline than 
control implant (1.50 mm2, P < 0.001; Fig. 6).  For adults, however, no significant 
difference was observed in any of the categories (Tables 3 and 4; Fig. 6).  The results of a 
two-way ANOVA suggested that tissue loss was affected by treatment (bicuculline vs. 
control) (F1,44 = 5.60, P < 0.02), but not age (F1,44 = 3.02, P < 0.09; Table 5). There was 
not a significant interaction between the two (P < 0.145; Fig. 7A).  For neuron loss, there 
was a significant effect of both age (F1,44 = 9.69, P < 0.003) and treatment (F1,44 = 7.38, P 
< 0.01). Again, there was no significant interaction between age and treatment (P < 0.07, 
Table 5; Fig. 7B). In the category of histological disruption there was a significant effect 
of age (F1, 44  = 55.33, P < 0.001) but not of treatment (P < 0.07).  There was significant 
interaction between age and treatment (F1,44 = 4.17, P < 0.05, Table 5; Fig. 7C).    When 
all categories were combined for the summed effect, there were effects of both age (F1,44 
= 39.34, P < 0.001) and treatment (F1,44 = 4.05, P < 0.05), and a significant age by 
treatment interaction (F1,44 = 5.68, P < 0.02, Table 5; Fig. 7D). 
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The effects of the control implant were significantly greater in young than adult 
cortex in tissue loss (F1,23 = 9.51, P < 0.005; Table 6), histological disruption (F1,23 = 
20.61, P < 0.0002), and summed effect (F1,23 = 11.17, P < 0.003; Table 6).  The effects of 
the bicuculline implant were significantly greater in young than adult cortex in neuron 
loss ((F1,23 = 8.23, P < 0.01; Table 6), histological disruption (F1,23 = 34.75, P < 0.0001; 





Figure 2.  Spontaneous activity under cortical implants.  Shown are data from 
barrel cortex of a P12 rat, 4 days after placement of the implants.  In this example, 
spontaneous activity appears slightly increased under the bicuculline implant than 
under the control implant from the cortical surface to a depth of 1300 µm.  















































Figure 3.  Examples of thionin-stained cells within the area of histological 
disruption, including apoptotic neurons (A and C, closed arrows), apoptotic glial cells (B, 









Figure 4.  Tissue disruption under a polymer implant.  (A) Photograph of thionin-
stained section after a four-day exposure to a control implant on the left and bicuculline 
implant on the right.  (B) Schematic reconstruction to illustrate defined areas of effects 





Figure 5.  Affected areas under the implant.  (A) Photograph of cortex under a bicuculline 
implant on a P12 rat. (B) Boundaries of areas of cortical effects are superimposed over 
the image.  Numbers refer to (I) tissue loss, (II) neuron loss, and (III) histological 
disruption.  Scale bars, 1 mm. 







Effects of Bicuculline and Control Implants in Rats 
 









 0.30 ± 0.07 0.38 ± 0.09 3.10 ± 0.40 3.77 ± 0.45 
Control 
 -0.03 ± 0.06 0.10 ± 0.05 2.20 ± 0.26 2.27 ± 0.29 
(B minus C) 
 0.32 ± 0.08 0.28 ± 0.09 0.90 ± 0.23 1.50 ± 0.27 
PUPS 
(n = 13) 
One-Way 
ANOVA 
P <  0.001; 
Post-hoc 
P < 0.05 
P < 0.003  
(KW); 
Post-hoc 
P < 0.05 
(Dunnett's) 
P < 0.07 
P < 0.01; 
Post-hoc 
P < 0.05 
(Tukey ‘s) 
Bicuculline 
 0.32 ± 0.13 0.08 ± 0.05 0.42 ± 0.12 0.82 ± 0.28 
Control 
 0.24 ± 0.07 0.03 ± 0.03 0.68 ± 0.20 0.95 ± 0.26 
(B minus C) 
 0.07 ± 0.10 0.05 ± 0.06 -0.25 ± 0.13 -0.13 ± 0.14
ADULTS 
(n = 11) 
One-Way 
ANOVA 
P <  0.82 
(KW) 
P < 0.48 
(KW) 
P < 0.38 
(KW) P < 0.74 
 
Effects were calculated in mm2 for each section as mean area of affected tissue 
under the implant on the bicuculline side minus that on the control side (B minus 





Cortical Effects of Bicuculline 
 
 Pups (n = 13) 
Adults 




† ± 0.08 
P < 0.001 
0.07 ± 0.10 
P < 0.82 
 
0.25 
F1,22 = 3.98 
P < 0.06 
 
Neuron Loss 0.28 ± 0.09 P < 0.003 
0.05 ± 0.06 
P < 0.48 
 
0.23 
F1,22 = 4.01 




0.90 ± 0.23 
P < 0.07 
-0.25 ± 0.13 
P < 0.38 
 
1.15 
F1,22 = 17.36 
P < 0.001 
 
Summed Effect 1.50 ± 0.27 P < 0.01 
-0.13 ± 0.14 
P < 0.74 
 
1.63 
F1,22 = 23.12 
P < 0.001 
 
 
†Areas (in mm2) of affected tissue under the implant for each section (bicuculline 




Figure 6. Effects of bicuculline. Shown are mean areas per section of neuron loss, 
tissue loss, histological disruption, and summed effect under the bicuculline 
minus the control implant.  In cortex of pups, but not adults, bicuculline was 
associated with significant neuron loss, tissue loss, and summed effect  (one-way 
ANOVA ** P < 0.003, *** P < 0.001, and, * P < 0.01, respectively).  Each value 


































Results of Two-Way ANOVA in Rat Barrel Cortex Following Bicuculline 
Implants 
 




F = 3.02 F = 9.69 F = 55.33 F = 39.34 
Age 
P < 0.09 P <  0.003 P <  0.001 P < 0.001 
F = 5.60 F = 7.38 F = 1.33 F = 4.05 
Treatment 
P <  0.02 P < 0.01 P < 0.26 P < 0.05 










Figure 7.  Graphs of means tested for effects of age, treatment, and age-by-treatment 
interactions (see Table 5).  





































































Effects of Cortical Implants 
 




F = 9.51 F = 1.56 F = 20.61 F = 11.17 
Control 
P < 0.005 P <  0.22 P <  0.0002 P < 0.003 













 The developmental role of GABAA receptors was explored in rat whisker barrel 
cortex.  Blockade of GABAA receptors in young (P8-P12), but not adult cortex, resulted 
in significant neuron loss and tissue loss.  In addition, histological disruption was greater 
in young than adult cortex.  The results of this study suggest there is a neuroprotective 
role of GABAA receptors in developing cortex.  
GABA can act as a trophic signal that can accelerate growth and facilitate synapse 
formation during development (Belhage et al., 1988).  Increased synaptogenesis occurs 
during the second postnatal week (Kristt, 1978; White et al., 1997), and a marked 
increase in GABAergic synapses occurs between P10 and P15 (Micheva and Beaulieu, 
1996).  Blocking GABAA receptors at such a critical time in development could lead to a 
loss of GABAergic synapses, and possibly a consequent loss of neurons, particularly 
GABAergic neurons.  
Decreasing inhibition by GABAA receptor blockade could tip the balance in favor 
of increased cortical activity and release of glutamate.  The loss of neurons resulting from 
GABAA receptor blockade in young animals was coincident with a time when the cortex 
is transiently vulnerable to excitotoxic influences (Johnston 1995, 1996) mediated by 
glutamate receptors (McDonald et al., 1988; McDonald and Johnston, 1990, 1993). 
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Although specific characteristics of neurons lost in the present study were not 
determined, other studies have described populations of neurons with a selective 
vulnerability to excitotoxic injury (Tecoma and Choi 1989; Weiss et al., 1990; Storey et 
al., 1992; Young et al., 1999). 
Although GABAA receptors are not present on glia in vivo in barrel cortex 
(Fritschy et al., 1994; Lin et al., 1994), application of bicuculline in the developing rat 
cortex resulted in a significant loss of tissue, apparently including glia.  It is known that 
excitatory amino acids can also cause swelling and destruction of astrocytes (Kimelberg, 
1996).  Furthermore, the excitotoxic damage can become cyclic as the response of the 
swelling of the astrocytes causes the release of more glutamate (Choi and Rothman, 
1990; Choi, 1992).   
The mechanical insult of the surgery or implant contributed more to neuron loss 
and disruption in cortex of the pup than in the adult.  Cortical insults may result in loss of 
cells through temporary hypoxia, disturbances of the blood-brain barrier, or secondary 
apoptotic mechanisms (Wyszynski et al., 1989; Persico et al., 1997).  However, surgical 
procedures of the two implant sites did not differ, and trauma effects would have been 
comparable within animal.  Nevertheless, the effects of bicuculline in these experiments 
might be amplified by the perturbation of cortical surgery.  Furthermore, bicuculline 
methiodide may act on sites other than the GABAA receptor complex (Olsen et al., 1976; 
Mestagh and Wulfert, 1999, Seutin and Johnson, 1999). Additionally, there may be 
variability in the distribution of bicuculline through the cortex as dictated by differences 
in cortical density between the two age groups. 
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The age-dependent effect of bicuculline on histological disruption suggests that 
GABAA receptors may also be necessary for proper cortical organization during 
development.  Perhaps due to the substantial tissue and neuron loss, the surviving cells 
expand and/or shift to the newly vacated space, altering the cytoarchitecture.  
Cytoarchitectural remodeling following injury has been described previously (Isacson 
and Sofroniew, 1992; Ferrer, 1993; Redecker et al., 1998).  Activation of microglia 
(Streit, 1996), or an increase in the replication or migration of astrocytes (Norton et al., 
1992; Burtrum and Silverstein, 1993; Norenberg, 1996) may have also contributed to 
disruption of the normal cortical architecture.   
The results presented here indicate a significant loss of neurons and tissue in the 
developing rat cortex following a chronic application of bicuculline methiodide.  It is 
unclear if these effects are due to increased glutamate-receptor mediated activity or if the 
receptor blockade led to a loss of functional synapses and a subsequent loss of neurons. 
These results are consistant with the current theory that during the second postnatal week, 
cell survival requires an appropriate balance between excitatory and inhibitory systems 
(Ohkuma, et al., 1994; van den Pol et al., 1996; Ikonomidou et al., 1999, 2000). 
Furthermore, the neuroprotective role of GABAA receptors proposed here adds to the 
current view that GABA contributes to cortical development (Lauder et al., 1986, 1998; 
Belhage et al., 1988; LoTurco et al., 1995; Berninger et al., 1995; Kellogg 1998; Owens 









Cytochrome oxidase (CO) staining is used as a marker of mitochondrial oxidative 
metabolism.  Cytochromes are responsible for electron transport and oxidative 
phosphorylation that yield ATP.  It has been hypothesized that the more active the 
neuron, the greater the need for ATP, and the greater the cytochrome oxidase activity 
(Wong-Riley, 1979).  This link between metabolic processes and neuronal activity has 
been proposed in the somatosensory cortex (Wong-Riley and Welt, 1980, Land and 
Simons, 1985a).  CO staining is decreased with deafferentation (Land and Simons, 
1985b; Mjaatvedt and Wong-Riley, 1991) and other forms of sensory deprivation (Land 
and Akhtar, 1987; Wong-Riley and Welt, 1980; Rhoades et al., 1993; although see 
Garraghty et al., 1991).  Conversely, CO staining increases in the cortex following 
epilepsy (Gerebtzoff et al., 1979) or injury (Martin et al., 1997; Valla et al., 1999).  The 
predicted response in this study was greater CO staining in the cortex under the 
bicuculline than control implants, due to disinhibited activity. 
 
Methods 
Data presented here were obtained from some of the animals used for the 
experiment described in the main thesis.  Sections from 10 pups and 4 adults were used 
for CO staining.  Based on the procedure previously described (Wong-Riley, 1979), 
sections were stained for CO activity.  The slides were then dehydrated in a series of 
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alcohols, cleared in xylenes, and then coverslipped with DPX.  Qualitative comparison of 
staining was done within section. 
 
Results and Discussion 
Under both bicuculline and control implants, there was a decrease in cytochrome 
oxidase in areas with neuron loss (Fig. 8).  Occasionally there was an increase in 
cytochrome oxidase activity in areas adjacent to the site of neuron loss.  The decrease in 
staining is consistent with reduced CO activity in atrophic neurons following a cortical 
stab wound (Al Ali and Robinson, 1984).  The increased metabolic activity in the 






Figure 8.  Photograph of cytochrome oxidase staining in a P12 rat cortex that was 
exposed to a bicuculline polymer implant.  Increased CO staining  (arrows) can 





GABAA RECEPTOR BINDING 
 
 38
GABAA RECEPTOR BINDING 
Background 
GABAA receptor binding has been shown to be regulated with sustained changes 
in neural activity.  For example, following sensory deprivation, GABAA receptor binding 
is reduced in rat cortex (visual: Gordon et al., 1997; somatosensory: Skangiel-Kramska et 
al., 1994; Fuchs and Salazar, 1998).  The changes in activity-dependent receptor 
regulation may also depend on age.  For example, in response to increased activity, 
GABAA receptors are down-regulated in juvenile (P20-30) and up-regulated in adult rat 
slices (Shaw and Scarth, 1992).  In the present experiment, receptor autoradiography was 




Data presented here were obtained from some of the animals used for the 
experiment described in the main thesis.  Sections from three pups and three adults were 
used for these experiments.  The procedure for [3H]muscimol binding to GABAA was 
based on the methods of Mower et al. (1986).  Sections were preincubated in 0.31 M 
Tris-citrate (pH 7.1, 4ºC) solution for 20 min to remove endogenous GABA, then 
incubated in 10 nM [3H]muscimol (specific activity = 20 Ci/mmol; New England 
Nuclear, Boston, MA) at 4ºC for 40 min.  The sections were rinsed twice for 30 sec each 
in 4ºC Tris-citrate, followed by a brief dip in distilled water.  GABA (final concentration 
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1 mM) was added to the incubation solution to determine nonspecific binding.  Excess 
liquid from the rinses was removed quickly by aspiration and the sections were dried with 
a fan.  The autoradiography sections and tritium standards were exposed to tritium-
sensitive film (3H-Hyperfilms, Amersham, Arlington Heights, IL) in X-ray cassettes at 
4ºC for approximately 10 wk. 
A qualitative analysis of [3H]muscimol binding under each implant site was 
performed using a video-based computerized analysis system (MCID, Imaging Research, 
St. Catherines, Ont. Canada).  
 
Results and Discussion 
In this study, [3H]muscimol binding was reduced in areas of neuron and tissue 
loss under both bicuculline and control implants.  There appeared to be no obvious 
changes in [3H]muscimol levels within the laminae and cortical barrels of the area of 
histological disruption between the bicuculline and control sides.   GABAA receptor 




SYSTEMIC APPLICATION OF BICUCULLINE 
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SYSTEMIC APPLICATION OF BICUCULLINE 
Background 
In order to avoid the potential interaction between GABAA receptor blockade and 
the effects of the surgical implant procedure, bicuculline was systemically administered 
to developing rats.  Evidence of neuronal damage following systemic application of 
bicuculline in adult rat cortex has been demonstrated in another lab (Soderfeldt et al., 
1981, 1983).  Doses of 1.0 – 8.0 mg/kg bicuculline (i.p.) in developing pups can lead to 
epileptiform seizures including shaking, rearing, and alternating muscle contraction and 
relaxation, known as clonus (Turski et al., 1985; Zouhar, 1989; Baram and Snead, 1990).  
As described in the main text, significant neuron loss under the bicuculline implant was 
present after four days in the developing cortex.  By using cortical thickness as an index 
of tissue volume, substantial loss of neurons in the cortex following four days of systemic 
bicuculline administration might be uncovered.   
Methods 
The solution of GABAA receptor antagonist was prepared by dissolving 
bicuculline (Sigma Chemical Co., St. Louis, MO) in 0.1 M HCl, buffered to pH 5.0 with 
0.1 M NaOH.  The control solution was vehicle alone.  In trial experiments, a single dose 
of 2 mg/kg i.p. was sufficient to cause seizures, and often death within minutes. A 
concentration of 1.5 mg/kg was found to induce seizures, with no mortality. Death from 
systemic bicuculline application is possibly due to pulmonary edema (Kiessling et al., 
1981; Soderfeldt et al., 1983; Kreisman et al., 1987).  
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For 4 days, beginning on P8, unanesthetized rats were given a 0.1 ml daily 
injection of either the bicuculline solution (1.5 mg/kg i.p.; n = 3) or the control solution 
(n = 4).  After injections, the pups were monitored for 1 hr before they were returned to 
the mother.   
Tissue was prepared as previously described in the main thesis.  Drawings from 
Nissl stained somatosensory cortex were made using a camera lucida at a final 
magnification of 20X. The barrel field in the P8 rat was determined to be located 
approximately 1.2-2.1 mm posterior to bregma and 3.0-3.5 mm from midline (Sherwood 
and Timiras, 1970).  Cortical thickness from upper white matter through layer I was 
measured in mm using a digitizing data tablet.  Thirty-two measurements per animal were 
chosen to represent changes in cortical thickness (4 serial coronal sections in the 
posteromedial barrel field, 8 measurements from each hemisphere).  The thickness of the 
cortex from the two groups of animals was compared using a Student’s t-test.  
 
Results and Discussion 
In this experiment, the somatosensory cortical thickness with bicuculline 
injections was 1.41 ± 0.02 mm and with control injections, 1.42 ± 0.01 mm.  There was 
no significant difference (P < 0.50) in somatosensory cortical thickness between the 
control and bicuculline injections.  Perhaps the lack of significant loss in tissue volume 
may be due to a daily single exposure to the GABAA receptor rather than the chronic 
blockade provided by the implant.  However, the possibility of neuron loss from systemic 
bicuculline application cannot be rejected and could be further examined using 





BDNF AND CORTICAL ACTIVITY 
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BDNF AND CORTICAL ACTIVITY 
Background 
Neurotrophins have been associated with trophic support in the developing 
nervous system.  Recent literature suggests that brain-derived neurotrophic factor 
(BDNF) may go beyond this traditional role.  BDNF in adults appears to play a role in 
regulation of cortical activity and the GABAergic system.  
BDNF is upregulated by increased electrical activity.  For example, while BDNF 
mRNA levels are barely detectable in barrels normally, whisker stimulation increases it 
markedly (Rocamora et al., 1996).  It has been proposed that the up-regulation of BDNF 
is by the excitatory glutaminergic neurons (Zafra et al., 1992).  The rise in BDNF can 
also be demonstrated following periods of hyperexcitability (Zafra et al., 1990; Ernfors et 
al., 1991) and kainic acid seizure-induced activity (Zafra et al., 1990; Ballarin, 1991; Gall 
et al., 1991).  There is also an increase in BDNF in areas adjacent to electrolytic 
(Rocamora et al., 1992) and chemical (Kokaia et al., 1993) lesions.  Additionally, 
reduction of BDNF by antisense to BDNF mRNA in the developing brain increases 
neuronal loss following kainic acid seizures (Tandon et al., 1999).  
The barrel cortex, where there is a large concentration of GABAergic neurons and 
synapses, provides a good model to examine the relationship between BDNF and GABA.  
The disinhibition of the GABAergic system, as in the chronic application of bicuculline, 





Immunohistochemical methods were based on the protocol of Conner et al. 
(1997).  Implanted pups (n = 5) were prepared for antibody staining by perfusion with 2% 
paraformaldehyde (in 0.1 M phosphate buffer, pH 7.4.  Coronal sections (50-µm thick) 
were obtained using a sliding microtome and were stored free-floating in 0.1 M 
Millonig's buffer for no more than 24 hr, until processed.   
Sections were washed for 10 min in Tris-buffered saline (TBS) followed by a 20 
min incubation in TBS containing 0.25% Triton X-100.  The sections were then blocked 
in 5% goat serum and 2% bovine serum albumin in TBS for 60 min.  The free-floating 
sections were incubated with the primary anti-BDNF (50 ng/ml) provided by Dr. Qiao 
Yan (Amgen, Yan et al., 1997), containing 0.25% Triton X-100 and 5% goat serum in 
TBS.  Sections were incubated for 40-64 hr at 4ºC on a slow moving shaker.  The 
sections were then incubated with 1.5 µg/ml biotinylated goat anti-rabbit IgG (Vector 
Laboratories, Burlingame, CA) containing 0.25% Triton X-100 and 5% goat serum in 
TBS for 3 hr, followed by incubation with avidin-peroxidase complex (Elite ABC kit, 
Vector Laboratories, Burlingame, CA) for 90 min at room temperature.  The sections 
were rinsed with three changes of 0.1 M Tris-HCl buffer (15-30 min per rinse). The 
sections were then mounted and air-dried.  The sections were developed with 0.4% 
diaminobenzidine tetrahydrochloride, 0.06% nickel chloride, and 0.06% H2O2 in 0.1 M 
Tris-HCl buffer (pH 7.4), then rinsed two times in 0.1 M phosphate-buffered saline 
(PBS).  After being dehydrated in a series of ethanol and cleared in xylenes, the sections 




Results and Discussion 
BDNF immunoreactivity increased under both control and bicuculline implant sites, with 
a slightly greater increase in staining within the area of histological disruption of the 
bicuculline than the control side (Fig. 9).  These results are consistent with 
demonstrations of BDNF upregulation following addition of the GABAA receptor 
antagonist bicuculline (Metsis et al., 1993) or traumatic brain injury (Mattson and Scheff, 
1994).  However, this is the first reported example of injury or bicuculline-induced 
BDNF upregulation in developing rat cortex. 
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Figure 9.  Photograph of anti-BDNF staining under control implants in a P12 rat. 
Increased BDNF antibody staining is greater (arrow) under the bicuculline implant (A) 
than under the control implant (B).  Higher magnification (C) of cells positive for BDNF 






SELECTIVE VULNERABILITIES OF NEURONAL AND GLIAL POPULATIONS 
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SELECTIVE VULNERABILITIES OF NEURONAL AND GLIAL POPULATIONS 
Background 
Apoptosis or active programmed cell death, can be seen during the first month of 
normal cortical development (Raff et al., 1993; Ferrer et al., 1994), as well as after 
excitotoxic damage (Portera-Cailliau, 1995; Bennett et al., 1998; Huang et al., 1999; 
Zipfel et al., 1999).  Apoptotic cells can also be seen following traumatic injury (Liu et 
al., 1997; Newcomb et al., 1999; Pohl et al., 1999; Raghupathi et al., 2000)..  The purpose 
of this study was to examine the time course and selective vulnerabilities of the neuron 
and glia populations following implant surgery.  
 
Methods 
Eleven rat pups (P8) were implanted bilaterally on P8 as described in the main thesis.  
After 1 day (n = 4), 2 days (n = 4), and 4 days (n = 3), the animals were perfused and 
brains cryoprotected as previously described.  Sections were cut at 40 µm thickness and 
stained, dehydrated, and coverslipped.  
Lange et al.  (1999) described a method for identifying apoptotic cells in Nissl-
stained sections following injury using dark-field microscopy.  In this study, low-
magnification dark-field was only slightly useful in screening for apoptosis.  In dark-field 
microscopy, darkly stained structures like apoptotic bodies diffract the light rays and 
become apparent.  Due to the thickness of the sections and the large numbers of pyknotic 
cells, many areas were bright under dark-field magnification.  High-magnification bright-
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field was then necessary for confirmation of apoptosis.  Drawings from each of the Nissl 
stained sections through the barrel field were made using a camera lucida.  Four serial 
coronal sections (a total of 160 µm A-P in thickness) were chosen to represent the area of 
maximum damage under the implant.  Using a camera lucida at a final magnification of 
40X, affected areas in each section were outlined and measured in mm2 using a digitizing 
data tablet.  At a final magnification of 400X, apoptotic neurons and apoptotic glia were 
counted within three 450 µm X 450 µm regions in the area of histological disruption. 
Apoptotic neurons, were distinguished from the smaller glial cells, by their 
characteristically large size and pale cytoplasm (Vaughan, 1984). 
 The proportions of apoptotic neurons to apoptotic glia were then calculated on 
each side.  Statistical analysis was performed using Jandel SigmaStat software.  Effects 
of treatment and exposure time to implants were assessed with analysis of variance 
(ANOVA) followed by Tukey’s post-hoc analysis. 
  
Results and Discussion 
Apoptotic cells were identified by their shrunken cytoplasm and spherical apoptotic 
bodies within the cell (Portera-Cailliau et al., 1997).  Apoptotic neurons in the developing 
rat brains have been seen within 24 hours following excitotoxic damage (Portera-Cailliau 
et al., 1997; Ishimaru et al., 1999) and traumatic brain injury (Bittigau et al., 1999; Pohl 
et al., 1999).  In this study, apoptotic neurons and apoptotic glia were present in all 
animals, although it should be noted that the incidence of apoptotic cells was very low 
over the 4-day period (Table 7; Fig 10).  The cortical apoptotic neuron:glia ratio between 
the control and bicuculline sides was not significantly different after 1, 2, or 4 days of 
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exposure (Table 7, Fig. 11). In addition, the neuron:glia ratio between the bicuculline and 




Effects of Bicuculline Implants on Numbers of Apoptotic Cells 
 














1 day      
(n = 4) 27.8 ± 8.9 11.0 ± 4.4 16.8 ± 2.2 8.0 ± 3.0 2.2 ± 1.0 5.8 ± 2.2 2.1 ± 0.8
2 day      
(n = 4) 18.0 ± 2.1 9.0 ± 2.1 9.0 ± 2.7 4.25 ± 1.6 1.2 ± 0.5 3.0 ± 1.5 3.6 ± 2.2
4 day      
(n = 3) 7.7 ± 2.2 4.0 ± 1.5 3.7 ± 3.3 0.0 2.0 ± 0.6 -2.0 ± 0.6 -1.6 ± 1.8
 
  
Numbers of apoptotic cells under the implant for each section on the bicuculline 
side minus that on the control side.  Areas represent averages within three 450 X 







Figure 10.  Effects of implants on apoptotic cells.  Average numbers of apoptotic 

























Figure 11.  Apoptotic cells following cortical bicuculline implant.  Effects were 
calculated as the ratio of apoptotic neurons to apoptotic glia on the bicuculline 
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